IL-4 alters TLR7-induced B cell developmental program in lupus
Clinical Immunology · 2025
DOI: 10.1016/j.clim.2025.110472 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Immunology, 2025. Verfasst von Changming Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA. Hauptthemen laut MEDLINE: Toll-Like Receptor 7, Lupus Erythematosus, Systemic, B-Lymphocytes, Interleukin-4. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIH HHS, BLRD VA.
Abstract (Originalsprache)
TLR7 stimulation of T-bet+CD11c+IgD-CD27- double-negative 2 (DN2) B cells is crucial for autoantibody formation in systemic lupus erythematosus (SLE). Here, we show that administration of IL-4 for five weeks significantly reduced autoantibodies and T-bet+CD11c+ IgD- B cells in autoimmune BXD2 mice treated with R848, a TLR7 agonist. Single-cell transcriptomics analysis indicates that following two doses of in vivo administration, IL-4 redirected development toward follicular, CD23+ germinal center (GC), and DN4-like memory B cells compared to treatment with R848 alone. While IL-4 enhanced genes related to antigen processing and presentation, it also suppressed R848-induced Ki67+ GC B cells in vivo. In vitro stimulation of SLE patient B cells with a DN2 polarizing cocktail revealed that IL-4 reduced the expression of interferon response and DN2 signature genes, promoting a population of CD23+T-bet- DN4 B population. These findings suggest that developmental reprogramming by IL-4 counteracts TLR7-promoted DN2 and GC B cells in SLE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
- Clinical Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
- Department of Internal Medicine, Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, Las Vegas, NV 89154, USA.
- Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA; Medicine Service, Birmingham Veterans Affairs Health Care System, Birmingham, AL,…
Förderung
- NIAID NIH HHS
- NIH HHS
- BLRD VA
- NIAMS NIH HHS
- National Institutes of Health National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- Lupus Research Alliance
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Lu, C., Liu, S., Gao, M., Rubio, J., Chatham, W. W., Hsu, H. C., & Mountz, J. D. (2025). IL-4 alters TLR7-induced B cell developmental program in lupus. Clinical Immunology. https://doi.org/10.1016/j.clim.2025.110472
Vancouver
Lu C, Liu S, Gao M, Rubio J, Chatham WW, Hsu HC, et al. IL-4 alters TLR7-induced B cell developmental program in lupus. Clinical Immunology. 2025. doi:10.1016/j.clim.2025.110472
BibTeX
@article{Lu2025,
author = {Lu, Changming and Liu, Shanrun and Gao, Min and Rubio, Jose and Chatham, W Winn and Hsu, Hui-Chen and Mountz, John D},
title = {IL-4 alters TLR7-induced B cell developmental program in lupus},
journal = {Clinical Immunology},
year = {2025},
doi = {10.1016/j.clim.2025.110472}
}
EUVIMED